||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 527 active entries
104 West 70th Street
New York, New York 10023
United States of America, New York
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
MegaGene, Inc. is a developmental stage biotechnology company engaged in drug discovery to treat neurological disorders such as Alzheimer disease, Multiple Sclerosis, Autism, Strokes, and all forms of genetically transmitted disorders. Our R&D is focused on developing treatments using proprietary genomic technologies. MegaGene, Inc. is also involved in licensing potential therapeutic producst.
MegaGene Inc. is entirely owned by Medical Consultants International, Inc. a provider of healthcare solutions.
Last update of this entry: September 05, 2013